Most Active Stories
- Jim Costa Calls On Governor Brown To Issue Drought Declaration For California
- San Joaquin Valley Craft Distillers Ride National Trend
- Fighting Fire With Fire, The Future Of The Rim Fire Burn Area
- Fresno Chef Combines Turkey And Brisket For A Thanksgivukkah Feast
- Launching 11-Day Action, Advocates Urge McCarthy To Pass Immigration Reform
Valley Public Radio Staff
Mon April 1, 2013
Originally published on Fri April 5, 2013 5:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.